Is AbbVie Stock Too Cheap to Ignore at Today's Price?

Is AbbVie Stock Too Cheap to Ignore at Today's Price?

Key PointsSome valuation metrics suggest that AbbVie is a cheap stock. The company's growth prospects through 2030 look attractive.AbbVie is also an excellent dividend stock. 10 stocks we like better than AbbVie › AbbVie (NYSE: ABBV), a pharmaceutical leader, has faced some challenges over the past three years. The company is managing some patent cliffs and clinical setbacks that worried investors and dinged its stock price. Despite all that, th…

3 Top Dividend Stocks to Buy in December

Key Points AbbVie is a Dividend King that has proven its resilience. Ares Capital offers an ultra-high yield, with solid near-term and long-term growth prospects. Enbridge provides a highly reliable dividend plus attractive growth potential. Did you know that the latter part of December is…